Y Parlier

897 citations

25 papers · 670 indexed · h-index 13

Impact in

Pathology and Forensic Medicine top 5%
- Lymphoma Diagnosis and Treatment
Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research

Papers in

Genetics 10
- Chronic Lymphocytic Leukemia Research 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
Hematology 10
- Hematopoietic Stem Cell Transplantation 6
- Acute Myeloid Leukemia Research 3

Co-authors: A Najman J Stachowiak G Duhamel Norbert Claude Gorin R David Félix Reyes Pauline Brice Éric Lepage
Journals: Cancer (3 papers)Journal of Clinical Oncology (2 papers)British Journal of Haematology (1 paper)Lung Cancer (1 paper)New England Journal of Medicine (1 paper)
Partner nations: France South Africa Finland

In The Last Decade

Y Parlier

24 papers receiving 598 citations

Peers

Countries citing papers authored by Y Parlier

Since Specialization

Citations

This map shows the geographic impact of Y Parlier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Parlier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Parlier more than expected).

Fields of papers citing papers by Y Parlier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Parlier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Parlier. The network helps show where Y Parlier may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Y Parlier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Y Parlier Line = papers co-authored together Y Parlier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Vinorelbine (NVB) oral (NVBo) in combination with carboplatin (CBDCA) followed by maintenance therapy with single agent vinorelbine oral in stage III/IV non-small cell lung cancer (NSCLC): Final results of a multicenter international phase II trial Journal of Clinical Oncology ·W Kusiak, H.-N. Macha, Sonia Del Barco, D. Aubert, Mirjana Mitrović, Y Parlier, U. Gatzemeier	2006	0
2	Randomized study of vinorelbine–gemcitabine versus vinorelbine–carboplatin in patients with advanced non-small cell lung cancer Lung Cancer ·E.H. Tan, Aleksandra Szczęsna, Maciej Krzakowski, H.-N. Macha, U. Gatzemeier, K. Mattson, Martin Wernli, Pavel Reiterer, Rina Hui, Joachim von Pawel, Oscar Bertetto, Jean-Christophe Pouget, Маркелова Людмила Николаевна, Y Parlier, Raymond P. Abratt	2005	44
3	Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre phase II trial European Journal of Cancer ·Cesare Gridelli, C. Manegold, P Mali, Martin Reck, L Portalone, O. Castelnau, R. Stahel, Daniel Betticher, Miklos Pless, FisherDoug, D. Aubert, Маркелова Людмила Николаевна, Y Parlier, Filippo de Marinis	2004	36
4	Long‐term effects of interferon‐α in five HIV‐positive patients with chronic hepatitis B Journal of Viral Hepatitis ·Vincent Di Martino, F. Lunel, J.F. Cadranel, Mariusz Matyaszewski, Y Parlier, Y. Le Charpentier, P Opolon	1996	17
5	Administration of three cytokines instead of bone marrow transplantation in an HIV+ patient with high‐grade lymphoma European Journal Of Haematology ·J.P. Laporte, Sylvie Lesage, M. Woler, Y Parlier, Anne Daguenel, Elliott Hjduction Editor, NC Gorin	1994	3
6	Recombinant Interferon Alfa-2b Combined with a Regimen Containing Doxorubicin in Patients with Advanced Follicular Lymphoma New England Journal of Medicine ·Philippe Solal‐Céligny, Éric Lepage, Nicole Brousse, Félix Reyes, Corinne Haïoun, M Leporrier, Michel Peuchmaur, André Bosly, Y Parlier, Pauline Brice, Bertrand Coiffier, Christian Gisselbrecht	1993	185
7	Hydroxyurea versus interferon alfa-2b in chronic myelogenous leukaemia: Preliminary results of an open French multicentre randomized study European Journal of Cancer and Clinical Oncology ·A Broustet, Josy Reiffers, Gérald Marit, D Fière, J. Jaubert, J. Reynaud, J Pris, sahar Abdelnasser, Núria García-Muñoz, Harold Schwager, CharlesM. Sherover, Nicole Dastugue, Y Parlier	1991	10
8	Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease Cancer ·Aimery de Gramont, Christophe Louvet, M Krulik, Nicole Smadja, D Donadio, Baochao Zhai, Philippe Brissaud, E Antoine, Shailendra Kumar Shrivastav, Anandan Viswanathan, C Jacquillat, A Najman, Y Parlier, M Boiron, Dani Prihandoko	1987	5
9	Autologous bone marrow transplantation for acute leukaemia in remission British Journal of Haematology ·NC Gorin, P Hervé, Philippe Aegerter, A. H. Goldstone, D C Linch, D Maraninchi, Alan K. Burnett, W Helbig, Giovanna Meloni, Leo F. Verdonck, T. de Witte, Vittorio Rizzoli, Angelo Michele Carella, Y Parlier, B Auvert, John M. Goldman	1986	54
10	Preleukemic changes in cases of nonlymphocytic leukemia secondary to cytotoxic therapy analysis of 105 cases Cancer ·Aimery de Gramont, Christophe Louvet, M Krulik, Nicole Smadja, D Donadio, Jean-Philippe Laporte, Philippe Brissaud, Mark Smith, E Antoine, Shailendra Kumar Shrivastav, Anandan Viswanathan, C Jacquillat, A Najman, Y Parlier, M Boiron, Dani Prihandoko	1986	13
11	Autologous bone marrow transplantation in the treatment of poor prognosis non-Hodgkin's lymphomas European Journal of Cancer and Clinical Oncology ·Norbert Claude Gorin, A Najman, Luc Douay, Ch. Salmon, R David, J Stachowiak, Y Parlier, Manuel López, M. J. Oppenheimer, D Lecomte, Berdibay Shalabay, J.C. Petit, Frédéric Pène, P. K. Resmi, Marjan van den Akker, G Duhamel	1984	18
12	Delayed kinetics of recovery of haemopoiesis following autologous bone marrow transplantation. The role of excessively rapid marrow freezing rates after the release of fusion heat European Journal of Cancer and Clinical Oncology ·Norbert-Claude Gorin, Luc Douay, R David, J Stachowiak, Y Parlier, M. J. Oppenheimer, A Najman, G Duhamel	1983	21
13	Pipobroman therapy of polycythemia vera Blood ·A Najman, J Stachowiak, Y Parlier, Gorin Nc, G Duhamel	1982	16
14	[Protective effect of isaxonine against vincristine-induced neuropathy (author's transl)]. PubMed ·G Duhamel, Y Parlier	1982	3
15	Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas. A report of 131 cases Cancer ·Y Parlier, Norbert Claude Gorin, A Najman, J Stachowiak, DE Smith	1982	22
16	[Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)]. PubMed ·Y Parlier, Norbert Claude Gorin, J Stachowiak, A Najman, G Duhamel	1982	1
17	High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors European Journal of Cancer (1965) ·Norbert Claude Gorin, R David, J Stachowiak, Ch. Salmon, J.C. Petit, Y Parlier, A Najman, G Duhamel	1981	87
18	High dose combination chemotherapy (TACC) with and without autologous bone marrow transplantation for the treatment of acute leukaemia and other malignant diseases European Journal of Cancer (1965) ·Norbert Claude Gorin, A Najman, Ch. Salmon, 黄兴海, J.C. Petit, R David, J Stachowiak, Arbeitskreis "Human- und ökotoxikologisc, Y Parlier, G Duhamel	1979	22
19	Immunocompetence following autologous bone marrow transplantation. PubMed ·Gorin Nc, Y. Zheng, C Salmon, Stefanos Bennett, Philippe Rouger, B Fortier, Yehudah Shilo Groskin, Olivier M. Girard, Hirojuki Hiraoka, Y Parlier, A Najman, G Duhamel	1979	10
20	[High dose combination chemotherapy with and without autologous bone marrow transplantation in patients with solid tumors and acute leukemias. Kinetics of recovery of peripheral bloods cells (author's transl)]. PubMed ·NC Gorin, A Najman, R David, J Stachowiak, Arbeitskreis "Human- und ökotoxikologisc, 黄兴海, J Petit, Hirojuki Hiraoka, Y Parlier, 智樹中島, 宜昭土本, Carlos Ernesto Garrido Salmón, G Duhamel	1978	1

About Y Parlier

Y Parlier is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Virology and Oncology, having authored 25 papers that have together received 670 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (6 papers), Neutropenia and Cancer Infections (4 papers), Acute Myeloid Leukemia Research (3 papers), Lung Cancer Research Studies (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (321 citations), Hematology (199 citations), Genetics (182 citations), Oncology (301 citations) and Neurology (100 citations). Y Parlier has collaborated with scholars based in France, South Africa and Finland. Frequent co-authors include A Najman, J Stachowiak, G Duhamel, Norbert Claude Gorin, R David, Félix Reyes, Pauline Brice, Éric Lepage, Nicole Brousse and Corinne Haïoun. Their work appears in journals such as Cancer, Journal of Clinical Oncology, British Journal of Haematology, Lung Cancer and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact